Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Gibco™ Human CCL15 (MIP-5) Recombinant Protein, PeproTech®
E. coli Recombinant Protein
Supplier: Gibco™ 3004350UG
This item is not returnable. View return policy
SDSDocumentsProduct Certifications Promotions
DescriptionThis gene is located in a cluster of similar genes in the same region of chromosome 17. These genes encode CC cytokines, which are secreted proteins characterized by two adjacent cysteines. The product of this gene is chemotactic for T cells and monocytes, and acts through C-C chemokine receptor type 1 (CCR1). The proprotein is further processed into numerous smaller functional peptides. Naturally-occurring readthrough transcripts occur from this gene into the downstream gene, CCL14 (chemokine (C-C motif) ligand 14).
|Human CCL15 (MIP-5)|
|QFTNDAETEL MMSKLPLENP VVLNSFHFAA DCCTSYISQS IPCSLMKSYF ETSSECSKPG VIFLTKKGRQ VCAKPSGPGV QDCMKKLKPY SI|
|ELISA, Functional Assay, Western Blot|
|protein with no preservative|
|≥ 98% by SDS-PAGE gel and HPLC analyses.|
|C-C motif chemokine 15; C-C motif chemokine ligand 15; CCL15; CCL15(22-92); CCL15(25-92); CCL15(29-92); chemokine (C-C motif) ligand 15; chemokine CC-2; HCC-2; HCC-2 Lkn-1; HMRP-2 B; leukotactin 1; Leukotactin-1; LKN1; LKN-1; Macrophage inflammatory protein 5; MIP-1 delta; MIP-1 D; MIP5; MIP-5; MIP-5 MIP-1 d; Mrp-2 b; NCC3; NCC-3; NCC-3 MIP-1 D; NCC3MRP-2 B; new CC chemokine 3; SCYA15; SCYA15member 15; SCYL3; small inducible cytokine subfamily A (Cys-Cys), member 15; small-inducible cytokine A15; SY15|
Provide Content Correction
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok